Comment on: "The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia" by Spiel et al.
Messaris
Evangelos
E
Memos
Nikolaos
N
Frantzeskaki
Frantzeska
F
Economou
Venetia
V
Betrosian
Alex
A
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D004195:Disease Models, Animal; D019446:Endotoxemia / Q000097:blood* / Q000188:drug therapy; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000188:drug therapy; D015850:Interleukin-6 / Q000097:blood; D011486:Protein C / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar; D018805:Sepsis / Q000097:blood / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D015850:Interleukin-6; D011486:Protein C; D014409:Tumor Necrosis Factor-alpha